Incidence and Onset of Cytomegalovirus Infection in Kidney Transplant Recipients: 3 Months Compared to 6 Months of Prophylaxis

被引：0
|
作者：
West-Thielke, P. [1 ]
Schmiedeskamp, M. [1 ]
Aggarwal, N. [1 ]
Thielke, J. [1 ]
Oberholzer, J. [1 ]
Benedetti, E. [1 ]
机构：
[1] Univ Illinois, Chicago, IL 60680 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1547
引用
收藏
页码：480 / 480
页数：1
相关论文
共 50 条
  • [1] Decreased incidence of cytomegalovirus infection in thymoglobulin treated kidney transplant patients with 6 months valganciclovir prophylaxis.
    Akalin, E
    Bromberg, JS
    Sehgal, V
    Ames, S
    Daly, L
    Murphy, B
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 427A - 427A
  • [2] Valganciclovir prophylaxis extension from 3 to 6 months in high-risk pancreas-transplant recipients does not impact incidence of cytomegalovirus infection at 12 months
    Jorgenson, Margaret R.
    Marka, Nicholas
    Leverson, Glen E.
    Smith, Jeannina A.
    Odorico, Jon S.
    CLINICAL TRANSPLANTATION, 2021, 35 (08)
  • [3] Impact of a Preemptive Strategy After 3 Months of Valganciclovir Cytomegalovirus Prophylaxis in Kidney Transplant Recipients
    Blanco, Noemie Boillat
    Pascual, Manuel
    Venetz, Jean-Pierre
    Nseir, Ghaleb
    Meylan, Pascal R.
    Manuel, Oriol
    TRANSPLANTATION, 2011, 91 (02) : 251 - 255
  • [4] Incidence and Characteristics of Cytomegalovirus Infection Among R plus Lung Transplant Recipients Receiving 3 Months of Antiviral Prophylaxis
    Kabbani, D.
    Hijri, A.
    Garcia, C. Hernandez
    Malhi, H.
    Chandrarathne, S.
    Kapasi, A.
    Weinkauf, J.
    Halloran, K.
    Lien, D.
    Preiksaitis, J.
    Cervera, C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S238 - S239
  • [5] Decreased incidence of cytomegalovirus infection in thymoglobulin-treated transplant patients with 6 months of valganciclovir prophylaxis
    Akalin, E
    Bromberg, JS
    Sehgal, V
    Ames, S
    Murphy, B
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (01) : 148 - 149
  • [6] 6 months valganciclovir prophylaxis significantly decreases cytomegalovirus infection incidence in thymoglobulin treated transplant patients.
    Akalin, E
    Bromberg, JS
    Sehgal, V
    Ames, S
    Daly, L
    Murphy, B
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 495 - 495
  • [7] Ciprofloxacin Prophylaxis in Kidney Transplant Recipients Reduces BK Virus Infection at 3 Months But Not at 1 Year
    Wojciechowski, David
    Chanda, Ranjan
    Chandran, Sindhu
    Lee, Brian
    Webber, Allison
    Macaraig, Melanie
    Tomlanovich, Stephen
    Vincenti, Flavio
    TRANSPLANTATION, 2012, 94 (11) : 1117 - 1123
  • [8] Expanded valganciclovir prophylaxis in kidney transplant recipients is associated with lower incidence of cytomegalovirus infection
    Veceric-Haler, Zeljka
    Bizjak, Bostjan
    Romozi, Karmen
    Arnol, Miha
    CLINICAL NEPHROLOGY, 2017, 88 : S126 - S130
  • [9] EXTENDING VALGANCICLOVIR PROPHYLAXIS IN KIDNEY TRANSPLANT RECIPIENTS IS ASSOCIATED WITH LOWER INCIDENCE OF CYTOMEGALOVIRUS INFECTION
    Bizjak, Bostjan
    Veceric-Haler, Zeljka
    Romozi, Karmen
    Arnol, Miha
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 407 - 407
  • [10] Usefulness of a Preemptive Strategy after Three Months of Antiviral Prophylaxis for Cytomegalovirus in Kidney Transplant Recipients.
    Boillat, Noemie
    Pacual, Manuel
    Venetz, Jean-Pierre
    Meylan, Pascal R.
    Manuel, Oriol
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 550 - 550
12345